Maraviroc and NeuroAIDS Pathogenesis
Phase of Trial: Phase II/III
Latest Information Update: 06 Jan 2020
Price : $35 *
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 24 Jan 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Sep 2018.
- 11 Mar 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.